These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 6103157)

  • 1. Danger of withdrawal of vasodilator therapy in patients with chronic heart-failure.
    Hanley SP; Cowley A; Hampton JR
    Lancet; 1980 Apr; 1(8171):735-6. PubMed ID: 6103157
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Vasodilator therapy with prazosin for severe congestive heart failure--hemodynamic effects of oral single administration and chronic use (author's transl)].
    Akamatsu T; Suzuki A; Yamamoto T; Takahashi S; Kimata S; Hirosawa K
    Kokyu To Junkan; 1979 Sep; 27(9):991-7. PubMed ID: 538350
    [No Abstract]   [Full Text] [Related]  

  • 3. Prazosin and congestive heart failure: short- and long-term therapy.
    Rouleau JL; Warnica JW; Burgess JH
    Am J Med; 1981 Jul; 71(1):147-52. PubMed ID: 7246572
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of oral prazosin therapy on exercise hemodynamics in patients with severe chronic heart failure.
    Chatterjee K; Rubin SA; Ports TA; Parmley WW
    Am J Med; 1981 Jul; 71(1):140-6. PubMed ID: 7246571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute and chronic cardiocirculatory effects of oral prazosin in chronic refractory heart failure.
    Hayashi H; Sassa H; Oba M; Fukaya T; Okubo M; Niwa T; Matsui E
    Jpn Heart J; 1980 Nov; 21(6):827-36. PubMed ID: 7007686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of trimazosin and prazosin therapy on cardiac and exercise performance in outpatients with chronic congestive heart failure.
    Aronow WS; Danahy DT
    Am J Med; 1978 Jul; 65(1):155-60. PubMed ID: 356598
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term maintenance therapy with prazosin in congestive heart failure.
    Mehta J; Miles D; Iacona M; Conti CR
    Clin Cardiol; 1981 May; 4(3):139-45. PubMed ID: 6790215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Vasodilator therapy of congestive heart failure: comparison of hemodynamic effects after administration of nitroprusside i.v. and oral prazosin (author's transl)].
    Mauri F; Gronda E; Bossi M; Rovelli F
    G Ital Cardiol; 1980; 10(4):414-23. PubMed ID: 7439582
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effect of vasodilator treatment of chronic circulatory insufficiency on various polycardiographic parameters].
    Guzińska B; Nartowicz E
    Kardiol Pol; 1983; 26(7):565-70. PubMed ID: 6645153
    [No Abstract]   [Full Text] [Related]  

  • 10. [The effects of prazosin in patients with chronic refractory heart failure-acute hemodynamic effects of oral prazosin and long-term therapy (author's transl)].
    Honda T; Hiramori K; Haze K; Saito M; Fuseno H; Fukami K; Umemoto M; Tanaka N; Ikeda M
    Kokyu To Junkan; 1981 May; 29(5):527-35. PubMed ID: 7313357
    [No Abstract]   [Full Text] [Related]  

  • 11. Serial hemodynamic studies during the treatment of congestive heart failure with isolated low-dose oral prazosin therapy.
    Reyns PR; Romney D; Desser KB; Benchimol A
    Angiology; 1979 Dec; 30(12):850-5. PubMed ID: 533015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of prazosin in severe congestive heart failure. An echocardiographic study.
    Drăgulescu SI; Comşulea L; Streian C
    Med Interne; 1984; 22(1):29-33. PubMed ID: 6710045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Correlations between resting hemodynamics and exercise tolerance before and after prazosin therapy in patients with chronic congestive heart failure].
    Ogawa T; Sekiguchi T; Ishii M; Sugishita Y; Ito I
    Kokyu To Junkan; 1985 Feb; 33(2):171-7. PubMed ID: 4001595
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of prazosin vs placebo on chronic left ventricular heart failure.
    Aronow WS; Lurie M; Turbow M; Whittaker K; Van Camp S; Hughes D
    Circulation; 1979 Feb; 59(2):344-50. PubMed ID: 365391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ambulatory prazosin treatment of chronic congestive heart failure: development of late tolerance reversible by higher dosage and interrupted substitution therapy.
    Awan NA; Lee G; DeMaria AN; Mason DT
    Am Heart J; 1981 May; 101(5):541-7. PubMed ID: 7223594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vasodilator therapy--a physiologic approach to the treatment of heart failure.
    Braunwald E
    N Engl J Med; 1977 Aug; 297(6):331-3. PubMed ID: 876316
    [No Abstract]   [Full Text] [Related]  

  • 17. [Vasodilator treatment of chronic heart failure: a chronic double-blind trial with prazosin and erythrityl tetranitrate].
    Tomov I; Kaloianova A; Terzieva L; Elenkova A; Nikolov G
    Vutr Boles; 1981; 20(6):72-8. PubMed ID: 7039130
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral vasodilator therapy with prazosin in severe congestive heart failure.
    Awan NA; Mason DT
    Am Heart J; 1981 May; 101(5):695-700. PubMed ID: 7223616
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of vasodilator therapy on mortality in chronic congestive heart failure. Results of a Veterans Administration Cooperative Study.
    Cohn JN; Archibald DG; Ziesche S; Franciosa JA; Harston WE; Tristani FE; Dunkman WB; Jacobs W; Francis GS; Flohr KH
    N Engl J Med; 1986 Jun; 314(24):1547-52. PubMed ID: 3520315
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Marked early attenuation of hemodynamic effects of oral prazosin therapy in chronic congestive heart failure.
    Elkayam U; Lejemtel TH; Mathur M; Ribner HS; Frishman WH; Strom J; Sonnenblick EH
    Am J Cardiol; 1979 Sep; 44(3):540-5. PubMed ID: 474434
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.